Información del artículo
El Texto completo está disponible en PDF
References
[1.]
R.S. Wallis, M.S. Broker, J.Y. Wong, M.E. Hanson, D.O. Beenhouwer.
Granulomatous infections diseases associated with tumor necrosis factor antagonists.
Clin Infect Dis, 38 (2004), pp. 1261-1265
[2.]
L. Carmona, J.J. Gómez-Reino, V. Rodriguez-Valverde, D. Montero, E. Pascual-Gómez, E. Martin, et al.
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
Arthritis Rheum, 52 (2005), pp. 1766-1772
[3.]
D. Ponce de Leon, E. Acevedo-Vasquez, A. Sanchez-Torres, M. Cucho, J. Alfaro, R. Perich, et al.
Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.
Ann Rheum Dis, 64 (2005), pp. 1360-1361
[4.]
A. Lalvani.
Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy.
Chest, 131 (2007), pp. 1898-1906
[5.]
D. Ponce de Leon, E. Acevedo-Vasquez, S. Alvizuri, C. Gutierrez, M. Cucho, J. Alfaro, et al.
Comparison of an interferon-g assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a high TB-endemic population.
J Rheumatol, 35 (2008), pp. 776-781
[6.]
S. Casas, X. Juanola, X. Bordas, A. Andreu, R. Moure, F. Alcaide, et al.
Diagnóstico de infección tuberculosa en pacientes candidatos a tratamiento anti-TNFa: prueba de la tuberculina vs detección de IFN-gamma en sangre. Abstract: 141.
XIII Congreso de la SEIMC,
[7.]
E.M.S. Leyten, S.M. Arend, C. Prins, F.G.J. Cobelens, T.H.M. Ottenhoff, J.T. van Dissel.
Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.
Clin Vaccine Inmunol, 14 (2007), pp. 880-885
Copyright © 2008. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
